Efficacy of dual antiplatelet therapy as premedication before diagnostic cerebral digital subtraction angiography.
Yoon-Hee ChooYoung-Jin JungChul-Hoon ChangJong-Hoon KimPublished in: Journal of cerebrovascular and endovascular neurosurgery (2019)
The use of dual antiplatelet agents (aspirin and cilostazol) for 7 days before DSA may reduce the risk of cerebral DSA-induced TEC.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- subarachnoid hemorrhage
- optical coherence tomography
- high glucose
- computed tomography
- diabetic rats
- cerebral ischemia
- low dose
- coronary artery disease
- brain injury
- drug induced
- magnetic resonance imaging
- type diabetes
- endothelial cells
- cardiovascular disease
- cardiovascular events
- magnetic resonance
- oxidative stress
- contrast enhanced